. "0"^^ . "2016-12-31+01:00"^^ . . . . . "38132"^^ . . "Project is devoted to development of new targeted radiopharmaceuticals for specific molecular diagnostic PET imaging and for therapy of oncologic and neurologic diseases in nuclear medicine. The main agents developed for commercialization are [Lu-177]DOTA-Nimotuzumab for oncologic therapy, [18-F]Fluoroflumazenil for specific molecular imaging of epileptic centres,16alfa-[18F]fluorestradiol ([18F]FES) for molecular imaging of estrogen receptors and agent(s) based on bombesin labelled with 68-Ga or 64-Cu for diagnosis of prostate cancer."@en . "V\u00FDvoj nov\u00FDch c\u00EDlen\u00FDch radiofarmaceutick\u00FDch p\u0159\u00EDpravk\u016F pro diagnostick\u00E9 i terapeutick\u00E9 pou\u017Eit\u00ED v nukle\u00E1rn\u00ED medic\u00EDn\u011B a jejich biologick\u00E9 testov\u00E1n\u00ED"@cs . "targeted radiopharmaceuticals- cancer diagnosis and therapy- monoclonal antibodies- peptide analogues- F-18- Lu-177- Ga-68- Cu-64"@en . "24784"^^ . . . "2013-01-01+01:00"^^ . . "Projekt se zab\u00FDv\u00E1 v\u00FDvojem nov\u00FDch c\u00EDlen\u00FDch radiofarmak pro specifickou zobrazovac\u00ED molekul\u00E1rn\u00ED diagnostiku pomoc\u00ED PET a pro terapii onkologick\u00FDch a neurologick\u00FDch onemocn\u011Bn\u00ED v nukle\u00E1rn\u00ED medic\u00EDn\u011B. Hlavn\u00EDmi vyv\u00EDjen\u00FDmi p\u0159\u00EDpravky sm\u011Brovan\u00FDmi do komer\u010Dn\u00EDho vyu\u017Eit\u00ED jsou [Lu-177]DOTA-Nimotuzumab pro onkologickou terapii, [F-18]Fluoroflumazenil pro specifick\u00E9 molekulov\u00E9 zobrazen\u00ED epileptick\u00E9ho lo\u017Eiska, 16alfa-[18F]fluorestradiol ([18F]FES) radiofarmakum uva\u017Eovan\u00E9 v PET pro zobrazen\u00E9 specifick\u00FDch estrogenov\u00FDch receptor\u016F a prepar\u00E1ty analog\u016F peptidu bombesinu zna\u010Den\u00E9 Ga-68 pro diagnostiku karcinomu prostaty."@cs . "0"^^ . "1"^^ . "Development of new targeted radiopharmaceuticals for diagnostic and therapeutic utilization in nuclear medicine and their biological testing"@en . . . "0"^^ . . "1"^^ .